Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest Stanislaw Burzynski Stories

2014-01-08 12:30:29

HOUSTON, Jan. 8, 2014 /PRNewswire/ -- The Burzynski Clinic (BC) announced today the preliminary response to the allegations in the lawsuit filed by Texas Medical Board (TMB) at the Texas State Office of Administrative Hearing on December 11, 2013 against Stanislaw R. Burzynski, M.D., Ph.D. (SRB). The allegations claim that SRB used internet-based advertising regarding antineoplastons (ANP), and that it was false, misleading, and violated federal law. The allegations can be divided...

2013-11-26 16:24:43

HOUSTON, Nov. 26, 2013 /PRNewswire/ -- The Burzynski Clinic (BC) announced today the successful treatment of a child with recurrent diffuse intrinsic pontine gliosarcoma (DIPGGS) at the 4(th) Quadrennial Meeting of the World Federation of Neuro-Oncology in San Francisco. Pediatric gliosarcoma (GS) is a rare variant of glioblastoma multiforme. The pontine location of this tumor is unusual, invariably fatal and successful treatment was not yet described in medical literature. The...

2013-11-26 16:24:41

HOUSTON, Nov. 26, 2013 /PRNewswire/ -- The Burzynski Clinic (BC) announced today that it has presented the results of a phase II study of antineoplastons A10 and AS2-1 (ANP) in children with recurrent high-grade glioma at the 4(th) Quadrennial Meeting of the World Federation of Neuro-Oncology in San Francisco. There are no standard treatment recommendations for children with high-grade glioma after recurrence. New therapies are required for patients whose tumor recurs after...

2013-11-26 16:24:38

HOUSTON, Nov. 26, 2013 /PRNewswire/ -- The Burzynski Clinic (BC) announced today that it has presented the results of a phase II study of antineoplastons A10 and AS2-1 (ANP) in adult patients with recurrent glioblastoma multiforme (GBM) at the 4(th) Quadrennial Meeting of the World Federation of Neuro-Oncology in San Francisco. GBM accounts for 60% of the primary brain tumors in adults and represents the most frequently occurring and the most malignant form of such tumors. Treatment...

2013-11-26 16:24:37

HOUSTON, Nov. 26, 2013 /PRNewswire/ -- The Burzynski Clinic (BC) announced today that it made a presentation of the results of a phase II study of antineoplastons A10 and AS2-1 (ANP) in pediatric recurrent diffuse intrinsic pontine glioma (DIPG) at the 4(th) Quadrennial Meeting of the World Federation of Neuro-Oncology in San Francisco. Brainstem gliomas are rare tumors in which DIPG comprises a distinct group. Numerous trials have been conducted in DIPG without proving...

2013-03-07 08:25:49

Screening to take place at the San Luis Obispo International Film Festival on March 10 SAN LUIS OBISPO, Calif., March 7, 2013 /PRNewswire/ -- In the compelling follow-up to the internationally award-winning documentary, Burzynski, the Movie; Burzynski: Cancer is Serious Business, Part II explores the current status of Antineoplastons' clinical testing sanctioned by the United States Food & Drug Administration -- and features a modern story of the struggling journeys of cancer...

2011-07-12 08:00:00

NASHVILLE, Tenn., July 12, 2011 /PRNewswire/ --This August, Documentary Channel (DOC) celebrates the lives and work of some of the world's most extraordinary innovators. Featuring trailblazers in art, music, medicine; each remarkable documentary shares the stories of unique, inspired individuals courageous enough to change the world. Highlights include the popular six-part series "Innovators in Music:" an exploration of six world-famous musicians and how their creative impulse extends...